Comparative Effectiveness: The Dollars and Sense
November 13, 2009
- Location
Bloomington, Indiana: Cook Medical Headquarters
Map
Parking - Primary Sponsors
- Supporting Sponsor
- AIT Laboratories
- Overview
Comparative Effectiveness research provides and disseminates information on the relative strengths and weaknesses of various medical therapies. The stimulus package that was enacted earlier this year allocated $1.1 billion for Comparative Effectiveness research. It has the potential to create major changes for all organizations in the life sciences value chain—manufacturers of drugs and devices, suppliers and service providers, payers, hospitals, physicians, and patients.
This conference will examine the policy and implementation issues relating to Comparative Effectiveness research, including: How will life sciences firms be impacted and how can they best take advantage of Comparative Effectiveness research? Who should conduct and pay for such research? Government, the private sector or both? Who decides what research to conduct and how should it be used? What can the United States learn from existing Comparative Effectiveness research in other countries? What will be the role of the various participants in the health care system—industry, payers, hospitals, physicians, and patients—in answering these questions?
- Agenda
8:00 am – 9:00 am Registration and Breakfast 9:00 am – 9:15 am Welcome Kem Hawkins, President, Cook Group Incorporated 9:15 am – 10:15 am Keynote Presentation - What is Comparative Effectiveness and What are the Key Policy Issues Introduction: Dan Peterson, Vice President, Industry and Government Affairs, Cook Group Incorporated Speaker: Scott Gottlieb, M.D., Resident Fellow, American Enterprise Institute for Public Policy Research 10:15 am – 11:45 am Panel Presentation: The Policy Path for Comparative Effectiveness? Moderator: Dan Peterson, Vice President, Industry and Government Affairs, Cook Group Incorporated Panel Members: Ted Heise, Vice President Regulatory Scientific Affairs, Cook Incorporated Peter Schwarz, M.D., PhD, Facility Investigator, IU Center for Bioethics and Assistant Professor, IU School of Medicine Neil Pickett, Director, Health Policy Research and Analysis, Clarian Health 12:00 pm – 1:15 pm Lunch & Keynote: Perspectives from Abroad—Uses of Comparative Effectiveness Outside of the United States Introduction: Neal Roach, Partner, Taft Stettinius & Hollister LLP Speaker: Paul Keckley, Executive Director, Deloitte Center for Health Solutions 1:15 pm - 1:30 pm Break and Networking 1:30 pm - 3:00 pm Industry Panel Comparative Effectiveness: Expected Impacts on Life Science Companies Moderator: Todd Pedersen, Vice President Corporate Development, AIT Laboratories Panel Members: Greg Odle, Executive Vice President and General Manager, OrthoPediatrics Marc L. Berger, M.D., Vice President, Global Health Outcomes, Eli Lilly and Company John Kansky, Vice President, Business Development, Indiana Health Information Exchange Paul H. Van Cleave, B.S., M.Ed.; RHU (Registered Health Underwriter); Vice President – Operations, Bloomington, SIHO Insurance Services William R. Cast, M.D., CEO, NoMoreClipboard 3:00 pm – 3:15 pm Closing Remarks Speaker: Dan Peterson, Vice President, Industry and Government Affairs, Cook Group Incorporated
